Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies. The company has engineered an innovative Point of Care (POCare) platform. This system incorporates a portfolio of licensed POCare therapeutics, which are manufactured and prepared using automated, self-contained POCare technology within a cooperative network.
| Date | Est. | Actual | |
|---|---|---|---|
| Mar 26, 2026 | $2.50 | -$4.38 | Miss |
| Nov 13, 2024 | $1.70 | -$1.93 | Miss |
| Aug 9, 2024 | $1.40 | -$2.30 | Miss |
| May 21, 2024 | $0.40 | -$2.90 | Miss |
| Apr 8, 2024 | $1.80 | -$11.60 | Miss |
| Nov 13, 2023 | $1.00 | -$4.30 | Miss |